Senior Vice President, Finance
Tue, Jan 18, 2022
Jan 18
exercised or converted securities in PCRX
2,500 shares @ $10.81
Increased holdings by +16.50%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+2.95%
1M-7.55%
3M-1.79%
6M—
1Y—